Compliance of atrial fibrillation treatment with the ABC pathway in patients with concomitant diabetes mellitus in the Middle East based on the Gulf SAFE registry

31 August 2020 (08:30 - 08:30)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Jakub Gumprecht

Silesian Center for Heart Diseases (SCHD), Zabrze (Poland)

5 More presentations in this session

Presentation thumbnail

The effect of computer decision support on optimizing appropriate dosing of novel oral anticoagulant therapy in the IMPACT-AF study

Doctor J. Cox (Halifax, CA)

Abstract Slides

Presentation thumbnail

Motivational Interviewing to Support Oral AntiCoagulation adherence in patients with non-valvular Atrial Fibrillation (MISOAC-AF): a randomised clinical trial

Doctor A. Tzikas (Thessaloniki, GR)

Abstract Slides

Presentation thumbnail

Real-world adherence to non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation measured by an electronic medication event monitoring system

Doctor M. Delesie (Gent, BE)

Abstract Slides

Presentation thumbnail

Naxos study: risk of bleeding with oral anticoagulants in non-valvular atrial fibrillation patients in France

Professor N. Danchin (Paris, FR)

Abstract Slides

Presentation thumbnail

Comparison between non-vitamin K antagonist oral anticoagulants versus warfarin for the risk of dementia in Asian patients with non-valvular atrial fibrillation

Doctor S. Lee (Seoul, KR)

Abstract Slides

Access the full session

Session thumbnail

NOAC Dosing, Adherence and Treatment Effects

The Event

ESC Congress 2020

31 August 2020 08:30 CET

You may be interested in

Congress Session

Basic science and arrhythmia pathophysiology

Congress Session

Treatment strategies for atrial fibrillation in heart failure

Congress Session

Young Investigator Award Basic and Translational Science

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources